Jeroen Luyten

4.7k total citations · 1 hit paper
129 papers, 3.1k citations indexed

About

Jeroen Luyten is a scholar working on Materials Chemistry, Economics and Econometrics and Health. According to data from OpenAlex, Jeroen Luyten has authored 129 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Materials Chemistry, 26 papers in Economics and Econometrics and 23 papers in Health. Recurrent topics in Jeroen Luyten's work include Vaccine Coverage and Hesitancy (23 papers), Health Systems, Economic Evaluations, Quality of Life (22 papers) and Advanced ceramic materials synthesis (12 papers). Jeroen Luyten is often cited by papers focused on Vaccine Coverage and Hesitancy (23 papers), Health Systems, Economic Evaluations, Quality of Life (22 papers) and Advanced ceramic materials synthesis (12 papers). Jeroen Luyten collaborates with scholars based in Belgium, Netherlands and United Kingdom. Jeroen Luyten's co-authors include Olivier J. Wouters, Martin McKee, Philippe Beutels, Steven Mullens, J. Van Humbeeck, I. Thijs, Jean‐Pierre Kruth, Roselinde Kessels, Albert Jan van Hoek and Luk Bruyneel and has published in prestigious journals such as The Lancet, JAMA and Physical Review B.

In The Last Decade

Jeroen Luyten

120 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

2020 814 citations Olivier J. Wouters, Martin McKee et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeroen Luyten Belgium	27	907	579	506	382	363	129	3.1k
Kyung Hee Lee South Korea	37	825 0.9×	305 0.5×	384 0.8×	94 0.2×	93 0.3×	247	4.5k
Junjie Xu China	44	1.0k 1.1×	325 0.6×	348 0.7×	213 0.6×	39 0.1×	341	8.2k
Jia–Wen Guo China	26	1.2k 1.3×	107 0.2×	450 0.9×	56 0.1×	38 0.1×	137	2.9k
Antonio J. Ramírez Brazil	45	1.8k 2.0×	3.0k 5.2×	241 0.5×	56 0.1×	183 0.5×	247	7.7k
Chih‐Hung Chang United States	45	2.4k 2.6×	740 1.3×	1.0k 2.1×	59 0.2×	150 0.4×	211	6.5k
Jeff Hughes Australia	31	213 0.2×	345 0.6×	108 0.2×	187 0.5×	136 0.4×	145	3.9k
Henrik Jensen Denmark	49	502 0.6×	141 0.2×	1.5k 2.9×	1.1k 2.8×	322 0.9×	211	7.3k
Yan Qi China	34	1.7k 1.9×	671 1.2×	507 1.0×	46 0.1×	20 0.1×	245	5.7k
George W. Taylor United States	43	680 0.7×	420 0.7×	684 1.4×	112 0.3×	96 0.3×	137	8.8k
Mark S. Thompson United Kingdom	37	363 0.4×	200 0.3×	636 1.3×	40 0.1×	558 1.5×	128	5.0k

Countries citing papers authored by Jeroen Luyten

Since Specialization

Citations

This map shows the geographic impact of Jeroen Luyten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeroen Luyten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeroen Luyten more than expected).

Fields of papers citing papers by Jeroen Luyten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeroen Luyten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeroen Luyten. The network helps show where Jeroen Luyten may publish in the future.

Co-authorship network of co-authors of Jeroen Luyten

This figure shows the co-authorship network connecting the top 25 collaborators of Jeroen Luyten. A scholar is included among the top collaborators of Jeroen Luyten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeroen Luyten. Jeroen Luyten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ballaux, Dominique, Gerd Vanhaverbeke, Youri Taes, et al.. (2025). Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial. EClinicalMedicine. 81. 103106–103106. 2 indexed citations

Smet, Stefan De, Steffen Fieuws, Kaatje Goetschalckx, et al.. (2025). Home-based exercise and PHysical activity maintenance interventiOn after livEr traNsplantation: Impact of eXercise intensity (PHOENIX-Liver). BMJ Open Sport & Exercise Medicine. 11(1). e002436–e002436.

Verbakel, Jan Y., Ann Van den Bruel, Sibyl Anthierens, et al.. (2025). A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trial. The Lancet. 406(10512). 1599–1610.

Luyten, Jeroen, et al.. (2025). Measuring Experienced Utility in the Context of Health Economic Evaluation: A Narrative Overview. Health Science Reports. 8(5). e70754–e70754.

Digregorio, Marina, Tine De Burghgraeve, Jeroen Luyten, et al.. (2024). Behavioural impact of antibiotic stewardship in children in primary care: interviews with GPs and parents. JAC-Antimicrobial Resistance. 6(6). dlae207–dlae207. 2 indexed citations

Carrico, Justin, Sandra E. Talbird, André Bento‐Abreu, et al.. (2023). Public health impact and return on investment of Belgium’s pediatric immunization program. Frontiers in Public Health. 11. 1032385–1032385. 6 indexed citations

Burghgraeve, Tine De, et al.. (2023). Cost-effectiveness of point-of-care interventions to tackle inappropriate prescribing of antibiotics in high- and middle-income countries: a systematic review. Journal of Antimicrobial Chemotherapy. 78(4). 893–912. 7 indexed citations

Peeraer, Karen, et al.. (2023). Cumulative pregnancy rates of two strategies: Day 3 fresh embryo transfer followed by Day 3 or Day 5/6 vitrification and embryo transfer: a randomized controlled trial. Human Reproduction. 39(1). 62–73.

Zimmeren, Esther van, Timo Minssen, Walter Van Dyck, et al.. (2022). Compulsory licensing for expensive medicines. 1 indexed citations

10.

Luyten, Jeroen, Sandy Tubeuf, & Roselinde Kessels. (2020). Who should get it first? Public preferences for distributing a COVID-19 vaccine. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 57. 8 indexed citations

11.

Stoner, Charlotte R., Martín Knapp, Jeroen Luyten, et al.. (2020). The cognitive footprint of medication: A review of cognitive assessments in clinical trials. Journal of Clinical Pharmacy and Therapeutics. 45(4). 874–880. 1 indexed citations

12.

Wouters, Olivier J., Martin McKee, & Jeroen Luyten. (2020). Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. JAMA. 323(9). 844–844. 814 indexed citations breakdown →

13.

Annemans, Lieven, Philippe Beutels, David E. Bloom, et al.. (2020). Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective. Value in Health. 24(1). 105–111. 25 indexed citations

14.

Luyten, Jeroen, Luk Bruyneel, & Albert Jan van Hoek. (2019). Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument. Vaccine. 37(18). 2494–2501. 126 indexed citations

15.

Godderis, Lode, et al.. (2018). Productivity estimation in economic evaluations of occupational health and safety interventions: a systematic review. Scandinavian Journal of Work Environment & Health. 44(5). 458–474. 17 indexed citations

16.

Luyten, Jeroen, Roselinde Kessels, Peter Goos, & Philippe Beutels. (2015). Public Preferences for Prioritizing Preventive and Curative Health Care Interventions: A Discrete Choice Experiment. Value in Health. 18(2). 224–233. 51 indexed citations

17.

Luyten, Jeroen, et al.. (2007). Surface segregation in CuPt alloys by means of an improved modified embedded atom method. Physical Review B. 76(17). 16 indexed citations

18.

Snijkers, Frans, et al.. (2003). Aqueous tape casting of yttria stabilised zirconia using natural product binder. Journal of the European Ceramic Society. 24(6). 1107–1110. 59 indexed citations

19.

Creemers, Claude, et al.. (2003). Segregation and ordering at alloys surfaces: modelling and experiment confronted. Applied Surface Science. 219(1-2). 11–27. 26 indexed citations

20.

Kuypers, S., et al.. (1993). Superplasticity of CuO-doped ZrO2(Y2O3). Materials Science and Engineering A. 168(1). 45–47. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact